U-Shaped Association of Standardized Serum 25-Hydroxyvitamin D with Risk of Low Muscle Mass: A Population-Based Cross-Sectional Study

References

• Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):990s–991s. doi:10.1093/jn/127.5.990S
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
   PubMed Web of Science ®Google Scholar
• Chang CD, Wu JS, Mhuircheartaigh JN, et al. Effect of sarcopenia on clinical and surgical outcome in elderly patients with proximal femur fractures. Skeletal Radiol. 2018;47(6):771–777. doi:10.1007/s00256-017-2848-6
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC. Nutrition, frailty, and sarcopenia. Aging Clin Exp Res. 2017;29(1):43–48. doi:10.1007/s40520-016-0709-0
   PubMed Web of Science ®Google Scholar
• Casati M, Costa AS, Capitanio D, et al. The biological foundations of sarcopenia: established and promising markers. Front Med. 2019;6:184. doi:10.3389/fmed.2019.00184
   Web of Science ®Google Scholar
• Cranney A, Weiler HA, O’Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr. 2008;88(2):513s–9s. doi:10.1093/ajcn/88.2.513S
   PubMed Web of Science ®Google Scholar
• Naesgaard PA, León De La Fuente RA, Nilsen ST, et al. Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLoS One. 2012;7(9):e43228. doi:10.1371/journal.pone.0043228
   PubMed Web of Science ®Google Scholar
• Freedman LP. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J Nutr. 1999;129(2S Suppl):581s–6s. doi:10.1093/jn/129.2.581S
   PubMedGoogle Scholar
• Bischoff HA, Borchers M, Gudat F, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J. 2001;33(1):19–24. doi:10.1023/A:1017535728844
   PubMedGoogle Scholar
• Mizuno T, Hosoyama T, Tomida M, et al. Influence of vitamin D on sarcopenia pathophysiology: a longitudinal study in humans and basic research in knockout mice. J Cachexia Sarcopenia Muscle. 2022;13(6):2961–2973. doi:10.1002/jcsm.13102
   PubMed Web of Science ®Google Scholar
• Kim Y, Chang Y, Ryu S, et al. Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults. Eur J Endocrinol. 2022;186(4):477–487. doi:10.1530/EJE-21-1229
   PubMed Web of Science ®Google Scholar
• Ko MJ, Yun S, Oh K, Kim K. Relation of serum 25-hydroxyvitamin D status with skeletal muscle mass by sex and age group among Korean adults. Br J Nutr. 2015;114(11):1838–1844. doi:10.1017/S0007114515003633
   PubMed Web of Science ®Google Scholar
• Kim MK, Baek KH, Song KH, et al. Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009. J Clin Endocrinol Metab. 2011;96(10):3250–3256. doi:10.1210/jc.2011-1602
   PubMed Web of Science ®Google Scholar
• Park S, Ham JO, Lee BK. A positive association of vitamin D deficiency and sarcopenia in 50 year old women, but not men. Clin Nutr. 2014;33(5):900–905. doi:10.1016/j.clnu.2013.09.016
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim S, Kim MK, et al. Relationships between 25(OH)D concentration, sarcopenia and HOMA-IR in postmenopausal Korean women. Climacteric. 2018;21(1):40–46. doi:10.1080/13697137.2017.1395410
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhou Y, Wu Q, et al. Prevalence of cardiovascular diseases in relation to total bone mineral density and prevalent fractures: a population-based cross-sectional study. Nutr Metab Cardiovasc Dis. 2022;32(1):134–141. doi:10.1016/j.numecd.2021.09.009
   PubMed Web of Science ®Google Scholar
• Golabi P, Gerber L, Paik JM, Deshpande R, de Avila L, Younossi ZM. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Rep. 2020;2(6):100171. doi:10.1016/j.jhepr.2020.100171
   PubMedGoogle Scholar
• Cromwell EA, Osborne JCP, Unnasch TR, et al. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning. PLoS Negl Trop Dis. 2021;15(7):e0008824. doi:10.1371/journal.pntd.0008824
   PubMed Web of Science ®Google Scholar
• Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat. 2013;56:1–37.
   PubMedGoogle Scholar
• Batsis JA, Mackenzie TA, Emeny RT, Lopez-Jimenez F, Bartels SJ. Low lean mass with and without obesity, and mortality: results from the 1999–2004 national health and nutrition examination survey. J Gerontol A Biol Sci Med Sci. 2017;72(10):1445–1451. doi:10.1093/gerona/glx002
   PubMed Web of Science ®Google Scholar
• Rippberger PL, Emeny RT, Mackenzie TA, Bartels SJ, Batsis JA. The association of sarcopenia, telomere length, and mortality: data from the NHANES 1999–2002. Eur J Clin Nutr. 2018;72(2):255–263. doi:10.1038/s41430-017-0011-z
   PubMed Web of Science ®Google Scholar
• Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–558. doi:10.1093/gerona/glu010
   PubMed Web of Science ®Google Scholar
• Moshfegh AJ, Rhodes DG, Baer DJ, et al. The US department of agriculture automated multiple-pass method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88(2):324–332. doi:10.1093/ajcn/88.2.324
   PubMed Web of Science ®Google Scholar
• Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99(1):427–511. doi:10.1152/physrev.00061.2017
   PubMed Web of Science ®Google Scholar
• Welch C, Hassan-Smith ZH, Greig CA, Lord JM, Jackson TA. Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults. Aging Dis. 2018;9(1):151–164. doi:10.14336/AD.2017.0315
   PubMed Web of Science ®Google Scholar
• Wiedmer P, Jung T, Castro JP, et al. Sarcopenia - molecular mechanisms and open questions. Ageing Res Rev. 2021;65:101200. doi:10.1016/j.arr.2020.101200
   PubMed Web of Science ®Google Scholar
• Tournadre A, Vial G, Capel F, Soubrier M, Boirie Y. Sarcopenia. Joint Bone Spine. 2019;86(3):309–314. doi:10.1016/j.jbspin.2018.08.001
   PubMed Web of Science ®Google Scholar
• Koshikawa M, Harada M, Noyama S, et al. Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications. BMC Cardiovasc Disord. 2020;20(1):228. doi:10.1186/s12872-020-01514-0
   PubMed Web of Science ®Google Scholar
• Hida T, Imagama S, Ando K, et al. Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: the Yakumo study. Mod Rheumatol. 2018;28(2):345–350. doi:10.1080/14397595.2017.1349058
   PubMed Web of Science ®Google Scholar
• Gao D, Trayhurn P, Bing C. 1,25-dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes. 2013;37(3):357–365. doi:10.1038/ijo.2012.53
   PubMed Web of Science ®Google Scholar
• Wamberg L, Cullberg KB, Rejnmark L, Richelsen B, Pedersen SB. Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. Horm Metab Res. 2013;45(6):456–462. doi:10.1055/s-0032-1331746
   PubMed Web of Science ®Google Scholar
• Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous national health and nutrition examination survey 2001 to 2006). Am J Cardiol. 2012;109(2):226–230. doi:10.1016/j.amjcard.2011.08.032
   PubMed Web of Science ®Google Scholar
• Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89(5):1321–1327. doi:10.3945/ajcn.2008.27004
   PubMed Web of Science ®Google Scholar
• Heaney RP. Vitamin D--baseline status and effective dose. N Engl J Med. 2012;367(1):77–78. doi:10.1056/NEJMe1206858
   PubMed Web of Science ®Google Scholar
• Li CW, Yu K, Shyh-Chang N, et al. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle. 2019;10(3):586–600. doi:10.1002/jcsm.12417
   PubMed Web of Science ®Google Scholar
• Singh NA, Quine S, Clemson LM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial. J Am Med Dir Assoc. 2012;13(1):24–30. doi:10.1016/j.jamda.2011.08.005
   PubMed Web of Science ®Google Scholar
• Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D deficiency and sarcopenia in older persons. Nutrients. 2019;11(12):2861. doi:10.3390/nu11122861
   PubMed Web of Science ®Google Scholar
• Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int. 2013;24(5):1567–1577. doi:10.1007/s00198-012-2231-3
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol. 2014;810:500–525. doi:10.1007/978-1-4939-0437-2_28
   PubMedGoogle Scholar
• Kim JA, Hwang SY, Yu JH, et al. Association of the triglyceride and glucose index with low muscle mass: KNHANES 2008–2011. Sci Rep. 2021;11(1):450. doi:10.1038/s41598-020-80305-1
   PubMed Web of Science ®Google Scholar
• Launer LJ, Harris T, Rumpel C, Madans J. Body mass index, weight change, and risk of mobility disability in middle-aged and older women. the epidemiologic follow-up study of NHANES I. JAMA. 1994;271(14):1093–1098. doi:10.1001/jama.1994.03510380049036
   PubMed Web of Science ®Google Scholar
• Berghella AM, Contasta I, Marulli G, et al. Ageing gender-specific “Biomarkers of Homeostasis”, to protect ourselves against the diseases of the old age. Immun Ageing. 2014;11(1):3. doi:10.1186/1742-4933-11-3
   PubMedGoogle Scholar
• Bellan M, Andreoli L, Mele C, et al. Pathophysiological role and therapeutic implications of vitamin D in autoimmunity: focus on chronic autoimmune diseases. Nutrients. 2020;12(3):789. doi:10.3390/nu12030789
   PubMed Web of Science ®Google Scholar
• An HJ, Tizaoui K, Terrazzino S, et al. Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int J Mol Sci. 2020;21(16):5678. doi:10.3390/ijms21165678
   PubMed Web of Science ®Google Scholar
• Sainaghi PP, Bellan M, Antonini G, Bellomo G, Pirisi M. Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation. Rheumatology. 2011;50(12):2290–2296. doi:10.1093/rheumatology/ker314
   PubMed Web of Science ®Google Scholar
• Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766–5772. doi:10.1210/jc.2003-030604
   PubMed Web of Science ®Google Scholar
• Sainaghi PP, Bellan M, Carda S, et al. Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. Rheumatol Int. 2012;32(11):3365–3372. doi:10.1007/s00296-011-2170-x
   PubMed Web of Science ®Google Scholar